Research ArticleClinical Sciences
Evaluation of Treatment Response to Radiotherapy in Head and Neck Cancer with Fluorine-18 Fluorodeoxyglucose
Heikki Minn, Robert Paul and Aapo Ahonen
Journal of Nuclear Medicine September 1988, 29 (9) 1521-1525;
Heikki Minn
Robert Paul
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Evaluation of Treatment Response to Radiotherapy in Head and Neck Cancer with Fluorine-18 Fluorodeoxyglucose
Heikki Minn, Robert Paul, Aapo Ahonen
Journal of Nuclear Medicine Sep 1988, 29 (9) 1521-1525;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy
- Assessing Tumor Response to Therapy
- Evaluation of D-18F-FMT, 18F-FDG, L-11C-MET, and 18F-FLT for Monitoring the Response of Tumors to Radiotherapy in Mice
- Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment
- Nuclear medicine in imaging head and neck malignancies
- Prospective Comparison of 18F-FDG PET with Conventional Imaging Modalities (MRI, CT, and 67Ga Scintigraphy) in Assessment of Combined Intraarterial Chemotherapy and Radiotherapy for Head and Neck Carcinoma
- 2-[18F]Fluoro-2-deoxyglucose and Glucose Uptake in Malignant Gliomas before and after Radiotherapy: Correlation with Outcome
- Metastatic Adenopathy from Nasopharyngeal Carcinoma: Successful Response to Radiation Therapy Assessed by Color Duplex Sonography
- Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose